Sanofi (SNY)
Nasdaq: SNY · Pharmaceutical Preparations · Paris, FR · filing with the SEC since 2001
Who owns Sanofi
As filed with the SECHolders of 5% or more
2
Blackrock, Inc. holds 5.8% of Common Stock, as its SCHEDULE 13G/A filed Apr 23, 2025 says.
Directors and officers
0
report now, of 0 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 23, 2025 · Common Stock
Amundi
SCHEDULE 13G/A · filed Oct 26, 2026 · Common Stock/American Depositary Receipts/Convertible Bonds · 5.65% in Jul 22, 2026
What SNY reports owning in othersstakes of 5% or more, and other ties
Innate Pharma S.A. IPHA
SCHEDULE 13G/A · filed Apr 29, 2025 · Ordinary Shares, Euro 0.05 nominal value per share
AgomAb Therapeutics NV AGMB
SCHEDULE 13G · filed May 6, 2026 · Common Shares, no nominal value per share ("Common Shares")
Other ties the annual report names
Ablynx
An entity · subsidiary · owns, named in the 20-F filed Feb 17, 2026
Bioverativ
An entity · subsidiary · owns, named in the 20-F filed Feb 17, 2026
Blueprint Medicines (Netherlands) B.V.
An entity · subsidiary · owns, named in the 20-F filed Feb 17, 2026
Opella
An entity · subsidiary · owns, named in the 20-F filed Feb 17, 2026
Principia Biopharma Inc.
An entity · subsidiary · owns, named in the 20-F filed Feb 17, 2026
Euroapi
An investee · associate · invested in, named in the 20-F filed Feb 17, 2026
OPAL JV Co
An investee · associate · invested in, named in the 20-F filed Feb 17, 2026
Regeneron
An investee · associate · invested in, named in the 20-F filed Feb 17, 2026
Its Form 13F-HR for Jun 30, 2026 lists 10 holdings. The record carries no value for them.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.